ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Smith and Nephew Plc New

Smith and Nephew Plc New (SNN)

24,66
-0,13
(-0,52%)
Fermé 22 Décembre 10:00PM
24,655
-0,005
(-0,02%)
Après les heures de négociation: 1:59AM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
24,66
Prix Achat
-
Prix Vente
-
Volume échangé
2 985 631
24,585 Fourchette du Jour 24,85
23,65 Plage de 52 semaines 31,72
Cap du marché
Clôture Veille
24,79
Ouverture
24,75
Dernière Transaction
116405
@
24.66
Dernière heure de transaction
Volume financier
US$ 73 858 940
VWAP
24,7381
Volume moyen (3 m)
776 375
Actions en circulation
437 187 056
Rendement du Dividende
3.04%
Ratio Cours sur Bénéfices
16,20
Bénéfice par action (BPA)
0,6
Chiffre d'affairess
5,55B
Bénéfice net
263M

À propos de Smith and Nephew Plc New

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from... Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder. Show more

Secteur
Ortho,prosth,surg Appl,suply
Industrie
Ortho,prosth,surg Appl,suply
Siège social
Watford, Gbr
Fondé
1937
Smith and Nephew Plc New est coté dans le secteur Ortho,prosth,surg Appl,suply de la New York Stock Exchange avec le ticker SNN. Le dernier cours de clôture d'Smith and Nephew était de US$24,79. Au cours de la dernière année, les actions de Smith and Nephew ont été négociées dans une fourchette de prix de US$ 23,65 à US$ 31,72.

Smith and Nephew compte actuellement 437 187 056 actions en circulation. La capitalisation boursière d'Smith and Nephew est de US$10,84 milliard. Smith and Nephew a un ratio cours/bénéfice (ratio PE) de 16.20.

SNN Dernières nouvelles

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Latest expansion to the CORI◊ Surgical System portfolio provides a personalized solution for patients and surgeons Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today...

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless...

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for...

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a...

Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announced today that its LEGION Hinged Knee (HK) System is now available in the United States with proprietary OXINIUM...

First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces promising surgeon feedback from the first completed cases utilizing its new CATALYSTEM Primary Hip System...

3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications

New TOTAL ANKLE Patient-Matched Guides pair with Smith+Nephew’s Total Ankle replacement solution, designed to help surgeons save time and ensure accuracy while performing fewer steps than standard...

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.96-3.7470725995325.6225.724.65551737225.16693779DR
4-0.56-2.2204599524225.2225.9824.65561422625.43651165DR
12-6.25-20.219993529630.9131.35523.8577637526.59815884DR
26-0.55-2.1816739389125.2131.7223.8575843127.81534188DR
52-2.23-8.2930457419126.8931.7223.6583914426.97979475DR
156-7.61-23.582274558432.2736.6821.52592868027.46331313DR
260-23.3-48.582151793247.9652.2621.52578013030.99830346DR

SNN - Frequently Asked Questions (FAQ)

What is the current Smith and Nephew share price?
The current share price of Smith and Nephew is US$ 24,66
How many Smith and Nephew shares are in issue?
Smith and Nephew has 437 187 056 shares in issue
What is the market cap of Smith and Nephew?
The market capitalisation of Smith and Nephew is USD 10,84B
What is the 1 year trading range for Smith and Nephew share price?
Smith and Nephew has traded in the range of US$ 23,65 to US$ 31,72 during the past year
What is the PE ratio of Smith and Nephew?
The price to earnings ratio of Smith and Nephew is 16,2
What is the cash to sales ratio of Smith and Nephew?
The cash to sales ratio of Smith and Nephew is 0,77
What is the reporting currency for Smith and Nephew?
Smith and Nephew reports financial results in USD
What is the latest annual turnover for Smith and Nephew?
The latest annual turnover of Smith and Nephew is USD 5,55B
What is the latest annual profit for Smith and Nephew?
The latest annual profit of Smith and Nephew is USD 263M
What is the registered address of Smith and Nephew?
The registered address for Smith and Nephew is BUILDING 5, CROXLEY PARK, HATTERS LANE, HERTFORDSHIRE, WATFORD, WD18 8YE
Which industry sector does Smith and Nephew operate in?
Smith and Nephew operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
VNCEVince Holding Corp
US$ 4,70
(69,06%)
1,06M
SRFMSurf Air Mobility Inc
US$ 3,33
(23,79%)
376,77k
BBBlackBerry Limited
US$ 3,685
(23,66%)
40,8M
ALURAllurion Technologies Inc
US$ 0,3439
(22,87%)
744,34k
CLWClearWater Paper Corporation
US$ 30,26
(22,46%)
3,5M
IIPRInnovative Industrial Properties Inc
US$ 73,50
(-22,91%)
3,15M
KUKEKuke Music Holding Limited
US$ 0,31
(-20,51%)
61,48k
NVONovo Nordisk
US$ 85,00
(-17,83%)
53,81M
CANGCango Inc
US$ 5,08
(-11,81%)
2,44M
BNEDBarnes and Noble Education Inc
US$ 9,965
(-10,31%)
1,55M
QBTSD Wave Quantum Inc
US$ 6,638
(4,21%)
124,42M
PFEPfizer Inc
US$ 26,36
(2,29%)
116,33M
APOApollo Global Management Inc
US$ 171,03
(0,83%)
94,52M
TAT&T Inc
US$ 22,75
(0,80%)
93,94M
FFord Motor Company
US$ 9,885
(1,49%)
87,66M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock